Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in oral premalignant lesions
NCT00036283Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in Oral Precancerous Lesions, sponsored by Pfizer. Started Nov 2000; status: completed.
02
Drugs
celecoxib
03
Conditions
Oral Precancerous Lesions
Beyond the preview
Go deeper on NCT00036283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036283.